In recent months, Blue Water Biotech, Inc. (“Blue Water”) has evolved from a preclinical vaccine development company to a commercial stage pharmaceutical company after the purchase of several FDA ...
CINCINNATI, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Nasdaq: BWV) ("BWB" or the “Company”) today announced the acquisition of Proteomedix AG, a private, commercial-stage diagnostics ...
2023 has been a year of changing tides for Blue Water Biotech, and the last few months appear to be producing some particularly rough seas. With a freshly minted CEO, the biotech is redefining its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results